… anti-TNFα treatment offers considerable improvement in systemic inflammatory joint diseases,
many … Application of MRI sequences and use of intravenous injection of gadolinium-DTPA (…

… confirms the important therapeutic effect of blocking leukocyte … -treatment with steroids,
and/or a supplementary infusion at … with risankizumab (200 mg IV and 600 mg IV) showed a …

… AEs of anti-integrins, including infusion reactions and … summary treatment effects were
estimated using the random-effects … biologics are presented in Table IV. Similarly, no statistically …

… But the tumour-targeting and therapeutic effects have variable … malignancy IV 0.1, 0.5, or 1.0
mg/m 2 /d Six-hour IV infusions … Tumour necrosis factor alpha and IFNγ are now affirmed as …

… permission to reuse the content in many different ways. … risk of mild infusion reactions
following intravenous dosing.31 … , a similar GSK1995057 treatment effect was not apparent in …

… of many newer biologic therapies, showed a treatment burden of … Yet anti-TNF therapy, most
often intravenous infliximab or … at risk of infusion reactions and treatment failure.Because the …

… treatment of immune mediated diseases including rheumatoid arthritis (RA), ankylosing
spondylitis (AS), and psoriasis [1]. Many biological therapies … 2 h IV infusion MTX 6–16 mg/week …

… Treatment effect size was determined by a random effects … The study focused on the effect
of infliximab on more than one … Intravenous infusion of infliximab was added to MTX (10–…

… efficacy and safety of anti-TNF-α therapy and summarize the efficacy of anti-TNF-α therapy
… the status of anti-TNF-α therapy among the multiple available therapeutic options. Based on …

… Many reports indicate that a high-serum trough level of anti-… of CD, and anti-TNF therapy is
essential for treating patients … a steady loss of efficacy of anti-TNF therapy. To investigate the …